IDEXX LABORATORIES INC /DE Fair Value Disclosure
| Level 1 | Quoted prices in active markets for identical assets or liabilities that the entity can access at the measurement date | ||||
| Level 2 | Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities | ||||
| Level 3 | Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities | ||||
| (in thousands) | ||||||||||||||||||||||||||
| As of December 31, 2025 | Quoted Prices in Active Markets for Identical Assets (Level 1) | Significant Other Observable Inputs (Level 2) | Significant Unobservable Inputs (Level 3) | Balance as of December 31, 2025 | ||||||||||||||||||||||
| Assets | ||||||||||||||||||||||||||
Cross currency swaps (1) | $ | — | $ | 1,700 | $ | — | $ | 1,700 | ||||||||||||||||||
Foreign currency exchange contracts (1) | $ | — | $ | 2,793 | $ | — | $ | 2,793 | ||||||||||||||||||
| Liabilities | ||||||||||||||||||||||||||
Cross currency swaps (1) | $ | — | $ | 13,270 | $ | — | $ | 13,270 | ||||||||||||||||||
Foreign currency exchange contracts (1) | $ | — | $ | 6,661 | $ | — | $ | 6,661 | ||||||||||||||||||
Interest rate swap (2) | $ | — | $ | 446 | $ | — | $ | 446 | ||||||||||||||||||
Contingent Consideration | $ | — | $ | — | $ | 1,800 | $ | 1,800 | ||||||||||||||||||
| (in thousands) | ||||||||||||||||||||||||||
| As of December 31, 2024 | Quoted Prices in Active Markets for Identical Assets (Level 1) | Significant Other Observable Inputs (Level 2) | Significant Unobservable Inputs (Level 3) | Balance as of December 31, 2024 | ||||||||||||||||||||||
| Assets | ||||||||||||||||||||||||||
Money market funds (3) | $ | 139,626 | $ | — | $ | — | $ | 139,626 | ||||||||||||||||||
Cross currency swaps (1) | $ | — | $ | 3,501 | $ | — | $ | 3,501 | ||||||||||||||||||
Foreign currency exchange contracts (1) | $ | — | $ | 16,921 | $ | — | $ | 16,921 | ||||||||||||||||||
Interest rate swap (2) | $ | — | $ | 710 | $ | — | $ | 710 | ||||||||||||||||||
| Liabilities | ||||||||||||||||||||||||||
Cross currency swaps (1) | $ | — | $ | 33 | $ | — | $ | 33 | ||||||||||||||||||
Contingent Consideration | $ | — | $ | — | $ | 2,300 | $ | 2,300 | ||||||||||||||||||
Want the next IDEXX LABORATORIES INC /DE fair value disclosure the moment it drops?
Set a Sentinel and we'll alert you the moment IDEXX LABORATORIES INC /DE's next filing hits EDGAR. No credit card, your email never gets sold.
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Feb 20, 2026 | Showing above |
| 2024 | Feb 21, 2025 | |
| 2023 | Feb 22, 2024 | |
| 2022 | Feb 16, 2023 | |
| 2021 | Feb 16, 2022 | |
| 2020 | Feb 12, 2021 | |
| 2019 | Feb 14, 2020 | |
| 2018 | Feb 15, 2019 | |
| 2017 | Feb 16, 2018 | |
| 2016 | Feb 17, 2017 | |
| 2015 | Feb 17, 2016 | |
About Fair Value Disclosures
Fair value disclosures classify all assets and liabilities measured at fair value into a three-level hierarchy: Level 1 (quoted market prices), Level 2 (observable inputs like yield curves), and Level 3 (unobservable inputs requiring management estimates). The proportion of Level 3 assets directly reflects how much of the balance sheet depends on internal models rather than market evidence.
Key signals: a growing Level 3 balance relative to total fair-value assets increases valuation uncertainty and earnings volatility risk. Watch for transfers between levels — assets moving from Level 2 to Level 3 often signal deteriorating market liquidity. Unrealized gains and losses on Level 3 positions flow through earnings or other comprehensive income, so large swings deserve scrutiny. For financial institutions, examine the sensitivity disclosures that show how Level 3 valuations change under alternative assumptions. Compare the fair value of debt against its carrying amount to gauge hidden leverage.